Benchmark given variation to marketing authorisation in Norway
(Sharecast News) - Aquaculture biotechnology company Benchmark has been granted a variation to its marketing authorisation for 'Ectosan Vet' from the Norwegian Medicines Agency, it announced on Tuesday.
Read more